全文获取类型
收费全文 | 1154篇 |
免费 | 96篇 |
国内免费 | 24篇 |
专业分类
儿科学 | 6篇 |
妇产科学 | 4篇 |
基础医学 | 49篇 |
口腔科学 | 2篇 |
临床医学 | 120篇 |
内科学 | 473篇 |
皮肤病学 | 2篇 |
神经病学 | 8篇 |
特种医学 | 31篇 |
外国民族医学 | 2篇 |
外科学 | 61篇 |
综合类 | 146篇 |
预防医学 | 67篇 |
眼科学 | 3篇 |
药学 | 53篇 |
2篇 | |
中国医学 | 7篇 |
肿瘤学 | 238篇 |
出版年
2024年 | 1篇 |
2023年 | 46篇 |
2022年 | 129篇 |
2021年 | 102篇 |
2020年 | 103篇 |
2019年 | 67篇 |
2018年 | 70篇 |
2017年 | 37篇 |
2016年 | 31篇 |
2015年 | 48篇 |
2014年 | 103篇 |
2013年 | 99篇 |
2012年 | 97篇 |
2011年 | 73篇 |
2010年 | 65篇 |
2009年 | 33篇 |
2008年 | 24篇 |
2007年 | 30篇 |
2006年 | 16篇 |
2005年 | 10篇 |
2004年 | 9篇 |
2003年 | 14篇 |
2002年 | 10篇 |
2001年 | 10篇 |
2000年 | 11篇 |
1999年 | 20篇 |
1998年 | 9篇 |
1997年 | 2篇 |
1996年 | 2篇 |
1994年 | 1篇 |
1992年 | 1篇 |
1991年 | 1篇 |
排序方式: 共有1274条查询结果,搜索用时 734 毫秒
1.
AimGenomic-based ancillary assays including immunohistochemistry (IHC) for BRCA-1 associated protein-1 (BAP1) and methylthioadenosine phosphorylase (MTAP), and fluorescence in situ hybridization (FISH) for CDKN2A are effective for differentiating pleural mesothelioma (PM) from reactive mesothelial proliferations. We previously reported a combination of MTAP and BAP1 IHC effectively distinguishes sarcomatoid PM from fibrous pleuritis (FP). Nevertheless, cases of sarcomatoid PM with desmoplastic features (desmoPM) are encountered where the IHC assessment is unclear.Methods and resultsWe evaluated assessment of MTAP IHC, BAP1 IHC, and CDKN2A FISH in 20 desmoPM compared to 24 FP. MTAP and BAP1 IHC could not be assessed in 11 (55 %) and 10 (50 %) cases, respectively, due to loss or faint immunoreactivity of internal positive control cells, while CDKN2A FISH could be evaluated in all cases. The sensitivities for MTAP loss, BAP1 loss, and CDKN2A homozygous deletion in desmoPM were 40 %, 10 %, and 100 %. A combination of MTAP loss and BAP1 loss yielded 45 % of sensitivity.ConclusionsMTAP IHC is a useful surrogate diagnostic marker in differentiating ordinary sarcomatoid PM from FP, but its effectiveness is limited in desmoPM. CDKN2A FISH is the most effective diagnostic assays with 100 % sensitivity and specificity in discriminating desmoPM from FP in the facilities where the FISH assay is available. 相似文献
2.
BackgroundNowadays surgery remains the gold standard of treatment for tongue cancer. Via a more clear and precise terminology, the glossectomy classification by Ansarin et al. facilitates shared communication between surgeons, allowing comparison between published research and improving surgical practice and patient care. To establish the association of glossectomies, according to their classification by Ansarin et al. with overall survival (OS), disease-free survival (DSF), and cause-specific survival (CSS) in tongue cancer, we conducted a systemic retrospective study on 300 consecutive patients affected by primary oral tongue cancer and treated with surgery at the European Institute of Oncology, IRCCS (IEO).MethodsThree hundred patients with tongue squamous cell carcinoma and treated at the Division of Otorhinolaryngology and Head and Neck Surgery of the European Institute of Oncology, IRCCS were cataloged according to the glossectomy classification. OS, DFS, and CSS were compared by surgical treatments.ResultsOS-5yrs was 80% for the type I glossectomy group, 75% for type II, 65% for type III, and 35% for type IV-V. DFS-5yrs was 74%, 60%, 55%, and 27%, respectively for I, II, III, and IV-V glossectomy group; CSS-5yrs was 82%, 80%, 72%, and 48%, respectively for I, II, III, and IV-V glossectomy group (p < 0.01).ConclusionsThis study confirmed that the application of the glossectomy classification was statistically correlated with patients' oncological outcomes. 相似文献
3.
《Clinical colorectal cancer》2020,19(4):285-290
BackgroundFOLFIRI (irinotecan, 5-fluorouracil, and leucovorin) + aflibercept improves median overall survival (OS) and progression-free survival (PFS) in patients with previously treated metastatic colorectal cancer (mCRC). Our aim was to investigate efficacy and tolerability of this combination in the first line.Patients and MethodsPatients with untreated documented mCRC received aflibercept plus FOLFIRI every 14 days until progression or unacceptable toxicity in an open, phase II single-arm, multicenter trial. The primary endpoint was the 6-month PFS rate. Secondary endpoints were OS and tolerability. A 2-step Simon design was used with H0: 55% and H1= 75%. Data were analyzed in intention to treat.ResultsForty-one patients were included, and 40 were analyzed (1 consent withdrawal) in 9 French centers between October 2014 and February 2017. The median age was 65 years (range, 46-81 years), 55% had ≥ 2 metastatic sites, and 50% and 15% had RAS and BRAF mutations, respectively. Twenty-two (54.5%; 95% confidence interval, 38.9%-68.5%) patients were alive and non-progressive at 6 months. FOLFIRI + aflibercept was considered ineffective, resulting in the cessation of inclusions. The median follow-up was 34 months. The overall response rate was 55%, and the disease control rate was 80%. The median duration of treatment was 5.3 months; the median PFS and OS were 8.2 and 18.6 months, respectively. Grade 3 to 4 adverse events were mainly gastrointestinal (47.5%) and vascular (32.5%). Of the patients, 87.5% had at least 1 dose modification.ConclusionAlthough the primary objective was not met, first-line FOLFIRI + aflibercept for mCRC leads to median PFS and OS close to those reported with classical doublet and targeted agents, but with significant toxicities needing dose reduction. 相似文献
4.
5.
目的: 探讨非活动性结核性胸膜炎与活动性结核性胸膜炎CT扫描影像表现。方法: 对2012年6月1日至2021年3月30日在首都医科大学附属北京胸科医院就诊的单纯非活动性结核性胸膜炎患者68例和同期活动性结核性胸膜炎44例的CT扫描影像表现进行比较。结果: (1) 68例非活动性结核性胸膜炎患者 CT扫描影像表现中胸膜粘连62例(91.2%),胸膜有钙化者28例(41.2%),叶间裂受累22例(32.4%),胸腔积液12例(17.6%),包裹性胸腔积液8例(11.8%)。(2)44例活动性结核性胸膜炎患者CT扫描影像表现中胸膜粘连30例(68.2%),未见胸膜钙化,叶间裂受累32例(72.7%),胸腔积液43例(97.7%),包裹性胸腔积液26例(59.1%)。(3)非活动性与活动性结核性胸膜炎CT扫描影像比较:胸膜粘连、胸膜钙化发生率高,差异均有统计学意义(χ2=9.630,P=0.002;χ2=23.737,P=0.000);叶间裂受累、胸腔积液、包裹性胸腔积液的发生率低,差异均有统计学意义(χ2=12.692,P=0.000;χ2=68.548,P=0.000;χ2=28.301,P=0.000)。结论: 非活动性结核性胸膜炎的CT扫描影像与活动性结核性胸膜炎比较胸膜粘连、胸膜钙化的发生率高,胸腔积液、包裹性胸腔积液、叶间裂受累的发生率低。识别非活动性和活动性结核性胸膜炎的CT扫描影像特点,对患者临床治疗有指导意义。 相似文献
6.
7.
8.
《Anaesthesia and Intensive Care Medicine》2007,8(6):248-252
Abdominal vascular surgery is required for aneurysmal and symptomatic occlusive disease of the aorta. Abdominal aortic aneurysms account for more than 8,500 deaths per year in England and Wales. Most deaths occur as a result of rupture of the abdominal aortic aneurysm, which has an overall mortality of 80%. These deaths are potentially preventable because elective repair of the abdominal aorta can be performed with an operative mortality of less than 7%. This article reviews the current indications and anaesthetic practices for open and endovascular abdominal aortic aneurysm repair. 相似文献
9.
目的探讨局部麻醉下经电视胸腔镜和胸部小切口诊治胸膜、肺部疾病的可行性。方法自2002年2月至2005年3月,对30例胸膜、肺疾病患者施行局部麻醉下开胸手术。按手术方法的不同将患者分为两组,小切口开胸组:16例,在局部麻醉下采用胸部小切口在开放性气胸状态下对增厚的胸膜和弥漫性肺疾病进行活组织检查;电视胸腔镜组:14例,在局部麻醉下经胸腔镜在闭合性气胸状态下诊治恶性胸水、复发性气胸等。结果小切口开胸组中行胸膜活检13例,其中10例为恶性肿瘤胸膜转移、胸膜淀粉样变1例、胸膜纤维增生样改变2例;弥漫性肺疾病活检3例,3例中肺间质性纤维化2例、型肺结核1例。电视胸腔镜组14例中,除1例因发现胸腔内有致密粘连而转行全身麻醉下开胸手术外,其余13例均在局部麻醉下完成胸膜活检,复发性气胸肺大泡切除,顽固性胸水的胸膜固定术;电视胸腔镜组中用胸腔镜辅助诊断为恶性胸水4例,肝性胸水1例;胸腔镜辅助治疗10例,其中顽固性(含肝性胸水)胸水行胸膜固定术8例,复发性气胸行肺大泡切除和胸膜固定术2例。两组患者均无手术并发症和死亡。结论局部麻醉下经胸腔镜及胸部小切口能够完成胸膜、肺疾病活检术及简单的手术。该方法经济、微创、对麻醉要求低,有利于临床普遍开展。 相似文献
10.
Jinyi Yuan Biwen Mo Zhuang Ma Yuan Lv Shih-Lung Cheng Yanping Yang Zhaohui Tong Renguang Wu Shenghua Sun Zhaolong Cao Jufang Wu Demei Zhu Liwen Chang Yingyuan Zhang 《Journal of microbiology, immunology, and infection》2019,52(1):35-44